with its host and in doing so, is highly efficient in undermining antiviral responses that 28 limit successful infections. As a result, HCMV infections are highly problematic in 29 individuals with weakened or underdeveloped immune systems including transplant 30 recipients and newborns. Understanding how HCMV controls the microenvironment of 31 an infected cell so as to favor productive replication is of critical importance. To this end, 32
we took an unbiased proteomics approach to identify the highly reversible, stress 33 induced, post-translational modification (PTM), protein S-nitrosylation, on viral proteins 34 to determine the biological impact on viral replication. 35
We identified protein S-nitrosylation of 13 viral proteins during infection of 36 highly permissive fibroblasts. One of these proteins, pp71, is critical for efficient viral 37 replication, as it undermines host antiviral responses, including STING activation. By 38 exploiting site-directed mutagenesis of the specific amino acids we identified in pp71 as 39 protein S-nitrosylated, we found this pp71 PTM diminishes its ability to undermine 40 antiviral responses induced by the STING pathway. Our results suggest a model in which 41 protein S-nitrosylation may function as a host response to viral infection that limits viral 42 spread. 43
In order for a pathogen to establish a successful infection, it must undermine the 47 host cell responses inhibitory to the pathogen. As such, herpesviruses encode multiple 48 viral proteins that antagonize each host antiviral response, thereby allowing for efficient 49 viral replication. Human Cytomegalovirus encodes several factors that limit host 50 countermeasures to infection, including pp71. We identified a previously unreported 51 modification of pp71 residues within the protein are protein S-nitrosylated. Using site-52 directed mutagenesis, we mutated the specific sites of this modification thereby blocking 53 this pp71post-translational modification. In contexts where pp71 is not protein S-54 nitrosylated, host antiviral response was inhibited. The net result of this post-translational 55 modification is to render a viral protein with diminished abilities to block host responses 56 to infection. This novel work supports a model in which protein S-nitrosylation may be an 57 additional mechanism in which a cell inhibits a pathogen during the course of infection.
INTRODUCTION 59
Human cytomegalovirus (HCMV) is a wide-spread betaherpesvirus that has 60 successfully established infections within the majority of the human population. The 61 incidence of HCMV sero-positivity increases with age (1) and infections are life-long, as 62 HCMV undergoes both lytic and latent lifecycles (2). The lytic lifecycle is highly efficient 63 at undermining the host antiviral responses (3), whereas during the latent stage the virus 64 remains dormant, thereby assuring immune evasion and allowing for lifelong infections 65 (4). Primary infections are often resolved by a competent immune system and maintenance 66 of the latent genome is often clinically inapparent. However, HCMV infections in 67 individuals with weakened or underdeveloped immune systems often result in poor 68 outcomes. For example, HCMV infections of neonates can cause developmental issues, 69 including premature births, blindness, deafness, and learning disabilities with incidence 70 rates exceeding that of congenital birth defects due to Zika virus infection (5) . Equally 71 problematic are viral reactivation events within immunosuppressed or immunodepleted 72 patient populations, such as organ recipients and those undergoing aggressive 73 chemotherapy. Viral reactivations within these individuals can lead to viremia, end-stage 74 organ failure, donor organ rejection, and graft versus host disease, all resulting in poor 75 patient prognosis (6). Consequently, HCMV is a significant economic and medical burden. 76 HCMV is a large DNA virus that encodes more than 200 open reading frames (ORFs) 77 (7, 8) , of which many remain uncharacterized, partly due to the lack of non-human model 78 systems. While there are related species of cytomegaloviruses, each have evolved to restrict 79 their infections to tissues derived only from their host species. Even with this restricted 80 tropism, cytomegaloviruses are highly successful pathogens, as these viruses have co-81 evolved with their hosts (9) and have acquired mechanisms to challenge known antiviral 82 responses (10). In many cases, cytomegaloviruses, including HCMV, not only undermine 83 these responses but also utilize them for the virus' own replication. One such example is 84 the viral tegument protein, pp71, encoded by the UL82 ORF (11). pp71 is critical for 85 efficient HCMV replication, as viruses that lack this ORF have severe growth defects (12, 86 purification and subsequent analyses (26). Thus, this PTM is significantly under-120 represented in the literature. 121
With recent advancements in whole cell proteomic analyses coupled with innovative 122 stable labeling of S-nitrosylated cysteines, the detection of protein S-nitrosylation can now 123 be applied to complex biological systems (27) . As the stress of HCMV infections result in 124 global and profound changes within host cells, including the stimulation of inducible nitric 125 oxide synthase (iNOS) (28), we sought to determine the biological impact of protein S-126 nitrosylation following HCMV infection. Herein, we evaluated the impact of HCMV 127 infection on the protein S-nitrosylation state on the proteome of infected fibroblasts using 128 unbiased, whole cell proteomics. We identified specific protein S-nitrosylated PTMs for a 129 subset of HCMV proteins, including pp71, a viral protein that limits host antiviral 130 responses including STING activation. Additionally, mutation of the protein S-nitrosylated 131 cysteines within pp71 to the closely related amino acid, serine resulted in increased 132 inhibition of STING antiviral responses, suggesting protein S-nitrosylation may negatively 133 impact the functions of viral proteins. We report that protein S-nitrosylation of pp71 is an 134 important regulatory mechanism that controls this viral protein's biological function. 135 Importantly, these findings suggest that protein S-nitrosylation of viral proteins by the host 136 cell machinery may function as a universal antiviral defense mechanism that may inhibit 137 multiple types of viruses. 138
MATERIALS AND METHODS 139

Cell culture 140
Primary newborn human foreskin fibroblasts (NuFF-1; GlobalStem) or primary human 141 embryonic lung fibroblasts (MRC5; ATCC) were maintained in Dulbecco's modified 142
Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 100 U/ml 143 each penicillin and streptomycin. Human Embryonic Kidney 293 FT cells (293FT; ATCC) 144 and amphomorphic phoenix cells (Phoenix-Ampho; ATCC) were maintained in DMEM 145 supplemented with 10% newborn calf serum (NCS) and 100 U/ml each penicillin and 146 streptomycin. Unless indicated, all cells were maintained at 37 C/5% CO2. 147 148
Biotin-switch assay and mass spectrometry 149
NuFF-1 cells were infected with TB40/E-mCherry-UL99eGFP (29) (herein referred to as 150 wild-type (WT) virus) at a multiplicity of infection (moi) of 3. Infected cells were harvested 151 96 hours post-infection (hpi), and the biotin-switch assay was conducted using S-152
Nitrosylated Protein Detection kit (Cayman), following the manufacturer's instructions. 153
Proteins were trypsinized, and biotinylated peptides were isolated by Avidin agarose resin 154 (Pierce). The eluates were evaporated using a SpeedVac centrifuge concentrator. Dried 155 samples were resuspended in 10 µL of 0.1% trifluoroacetic acid then purified by solid 156 phase extraction (SPE) using C18 Ziptip (stage-tip; EMD Millipore) following the 157 manufacture's protocol. Next, 5 μL of the extract in 1% acetic acid was injected and the 158 peptides eluted from the column (Dionex 15 cm x 75 μm id Acclaim Pepmap C18, 2μm, 159 100 Å reversed phase capillary chromatography column) by an acetonitrile/0.1% formic 160 acid gradient at a flow rate of 0.3 μL/min and were introduced into the source of the mass 161 spectrometer (LTQ-Obitrap Elite hybrid mass spectrometer, Finnigan). The 162 microelectrospray ion source was operated at 2.1 kV. The digest was analyzed using the 163 data-dependent multitask capability of the instrument, acquiring full-scan mass spectra to 164 determine peptide molecular weights and product ion spectra to determine amino acid 165 sequence in successive instrument scans. The data were analyzed by using all CID spectra 166 collected in the experiment to search the human and HCMV/HHV5 reference sequence 167 (NCBI:txid295027) with the search program, Sequest (30). Biological replicates from three independent infections of both HCMV-infected and mock samples were analyzed by mass 169 spectrometry. 170 171 BAC recombineering, virus production, and viral growth analyses. 172
Based on the mass spectrometry results, the identified S-nitrosylated cysteines (C) 173 were mutated to serine (S). S-nitrosylation-resistant mutants (pp71 single mutant, C218S 174 and triple mutant, C34S/C94S/C218S) were generated using the BAC-derived parental 175 virus, TB40/E-mCherry-UL99-eGFP, using the galK positive-/counter-selection scheme 176 of BAC recombineering, described previously (31). In brief, galK was amplified using 177 primers designed with 50-bp homology to the flanking region of each mutation site 178 (Supplemental Table 1 penicillin and streptomycin. After 100% cytopathic effect (CPE) was observed, infected 198 cells and media were collected and transferred to centrifuge tubes. Cells were pelleted and 199 supernatant was reserved. Virus was released from the cell pellets by resuspension in 10 200 ml of media and disruption by bath sonication. The medium was then cleared of cellular 201 debris, and the supernatant was added to the reserved medium. Virus was then purified by 202 ultracentrifugation through a 20% sorbitol cushion (20% sorbitol in 1X PBS) for 90 203 minutes (min) at 72,000 × g at 25°C. The resulting pellet was resuspended in 5mls of 204 DMEM supplemented with 10% FBS and 1.5% bovine serum albumin (BSA) in a 1:1 ratio 205 and aliquots were stored at −80°C following snap-freezing in liquid nitrogen. Virus stocks 206 were titered by 50% tissue culture infectious dose (TCID50) on naïve NuFF-1 cells. 207
Newly generated recombinant S-nitrosylation-resistant viruses (pp71 single mutant, 208 C218S and triple mutant, C34S/C94S/C218S) were compared to the parental, wild-type 209 TB40/E-mCherry-UL99eGFP (WT) by infecting a confluent monolayer of MRC5 cells at 210 an moi of 1 infectious unit (IU)/cell as quantified by TCID50 assay. Supernatants were 211 collected every day for a week and viral titers quantified by TCID50 assay on naïve NUFF-212 1 cells. 213 214
Generation of plasmids for transfection and transduction. 215
Primers were generated to amplify the different pp71 ORFs from the WT and recombinant 216 viruses for subsequent cloning into expression constructs using the primer sets 217 (Supplemental Table 1 ). FLAG-epitope tagged pp71-WT or pp71-C218S were generated 218 using the primers in Table S1 and the respective BAC constructs as templates. The PCR 219 products were digested with EcoRI and then cloned into pCMSeGFP (Clonetech) using the 220 EcoRI site within the multicloning site. To generate pp71-expressing MRC5 cells, pp71 221 WT or pp71 C218S were PCR amplified from the above BAC constructs and subsequently 222 cloned into the pLXSN retroviral vector (Clonetech) using the EcoRI site. pCDNA-223 STING-HA was a generous gift from Dr. Blossom A. Damania (UNC-Chapel Hill) (34). 224
To generate pp71 expressing retroviruses, phoenix cells were transfected with 1µg 225 of either pLXSN-pp71WT or pLXSN-pp71 C218S using Lipofectamine 2000 (Invitrogen) 226
according to the manufacture's protocol. Transfected Phoenix cells were washed, 227
replenished with media and maintained in at 32°C/5% CO2 for 2 d. The retrovirus-228 containing media was then clarified by low-speed centrifugation and added to MRC5 cells 229 at 70% confluency. The following day, successfully transduced MRC5 cells were selected 230 by adding 300 µg/mL G418 (Invitrogen) to the media. This selection treatment was 231 repeated for a total of two cell doublings of the MRC5 cells. 232 233
Co-immunoprecipitation and western blots 234
For western blotting experiments, total protein was extracted in lysis buffer (35) 235 containing 20 mM Hepes (pH 7.4), 50 mM NaCl, 1.5 mM MgCl2, 2 mM dithiothreitol 236 (DTT), 2 mM EGTA, 10 mM NaF, 12.5 mM β-glycerophosphate, 1 mM Na3VO4, 5 mM 237 Na-pyrophosphate, 0.2% (v/v) Triton X-100, and Complete protease inhibitors (Roche 238
Applied Science). An equal amount of protein (20 μg) was separated by 8% SDS-PAGE, 239 transferred to nitrocellulose/PVDF by semi-dry transfer, and then probed with the 240 following primary antibodies: anti-pp71 (1:100; 2H10-9 (14), anti-IE2 (1:100; 3A9 (36), 241 anti-pp65 (1:100; 8A8 (37), anti-STING (1:1000; D2P2F, Cell Signaling), anti-biotin 242
(1:75; Cayman), anti-FLAG (1:2000; Sigma-Aldrich), anti-HA (1:1000, Sigma Aldrich) 243 and anti-α-tubulin (1:5,000; Sigma-Aldrich). Membranes were incubated with a secondary 244 antibody: IRDye 800CW anti-rabbit antibody (1:15000, LI-COR) or IR-Dye 680RD anti-245 mouse antibody (1:15000, LI-COR). Membranes were then washed with 1X tris-buffered 246 saline (TBS), pH 7.6 supplemented with 0.05% Tween 20 (1xTBS-T), scanned using an 247
Odyssey (LI-COR), and protein bands were visualized by Image Studio software (LI-248
COR). 249
For all affinity/immunoprecipitation (IP) experiments, cells were harvested at 4 dpi 250 and lysed in IP lysis buffer containing 20 mM Hepes (pH 7.4), 50 mM NaCl, 1.5 mM 251
MgCl2, 2 mM DTT, 2 mM EGTA, 10 mM NaF, 12.5 mM β-glycerophosphate, 1 mM 252 Na3VO4, 5 mM Na-pyrophosphate, 0.2% (v/v) Triton X-100, and Complete protease 253 inhibitors (Roche Applied Science). To confirm S-nitrosylation of pp71, NuFF-1 cells were 254 infected at a multiplicity of 1 IU/cell with TB40/E-mCherry-UL99eGFP. After the biotin-255 switch assay, lysates were affinity-purified with avidin beads or immunoprecipitated with 256 the indicated antibody. Purified lysates were separated by 8% SDS-PAGE and blotted onto 257 Protran 0.45µm nitrocellulose membrane (Amersham). S-nitrosylated proteins were 258 detected by using HCMV-specific antibodies (1:100), as indicated, or an antibody against 259 biotin (1:75). 260
For IP, lysates were pre-cleared for 1 hour (h) with mouse immunoglobulin G (IgG) 261 agarose or rabbit immunoglobulin G (IgG) agarose (Sigma), dependent on the species of 262 antibody used in IP, incubated overnight with IP antibodies and then with protein A/G 263 beads for 1 h with rotation. After incubation, beads were washed with IP lysis buffer and 264 boiled with 4X Laemmli sample buffer. An equal amount of protein (20 μg) was separated 265 by 8% SDS-PAGE, transferred to nitrocellulose/PVDF, and then probed with the following 266 primary antibodies: anti-m2 FLAG (1:7,500; Sigma-Aldrich) and anti-α-tubulin (1:5,000; 267 Sigma-Aldrich). Both were visualized using a secondary antibody conjugated to 268 horseradish peroxidase (goat-anti-mouse HRP, 1:10,000; Jackson ImmunoResearch conditions, according to the manufacturer's instructions, and then precipitated with 280 isopropanol. DNA-contaminating templates were removed by DNAse treatment using the 281 DNA-free DNA Removal kit (Ambion). RNA concentrations were determined and equal 282 amounts (0.9 μg) were used to generate cDNA using the TaqMan reverse transcription kit 283 with random hexamers (Applied Biosystems), according to the manufacturer's protocol. 284
Equal amounts of cDNA (10 ng) were then analyzed by qPCR in triplicate using Power 285 SYBR Green Master Mix (Applied Biosystems) and an Eppendorf Mastercycler RealPlex2 286 real-time PCR machine. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) RNA 287 levels were quantified in parallel and used to normalize for the RNA isolation efficiency 288 of each sample. Viral RNA copy number was calculated using a standard curve generated 289 from HCMV BAC DNA, as above. 290
Immunofluorescence assay (IFA) 292 MRC5 cells were infected with BAC-derived TB40/E lacking a fluorescent marker (38) at 293 a multiplicity of 0.01 IU/cell. Cells that were harvested 6 dpi were washed three times with 294 37oC 1X PBS, and then fixed at 37oC with 2% paraformaldehyde for 15 min. The infected 295 cells were washed with 1X PBS three times at room temperature (RT) and then 296 permeabilized with 0.1% Triton X-100 for 15 min. Next, cells were washed with 0.2% 297 Tween 20 in 1X PBS three times, blocked in 2% BSA with 0.2% Tween 20 in 1X PBS at 298 RT for 1 h, and were then stained with the primary antibodies (pp71; 1:50 and STING; 299 1:100) at RT for 1 h. Cells were washed (0.2% Tween 20 in 1X PBS), and then stained 300 with secondary antibodies (anti-mouse Alexa Fluor 488; anti-rabbit Alexa Fluor 594) and 301 4',6-diamidino-2phenylindole (DAPI; to visualize nuclei) at RT for 1 h in the dark. Images 302 were collected on an Olympus 1X81 microscope. 303
304
RESULTS
306
Distinct HCMV proteins are S-nitrosylated during infection of fibroblasts. 307
Infection with viruses induces significant changes within a cell's proteome, including 308 PTM alterations. To monitor the changes in host cell protein S-nitrosylation in response to 309 infection, we infected human fibroblasts (MOI = 3.0) with a BAC-derived, clinical isolate 310 of HCMV that expresses a viral late protein, pp28 (encoded by UL99), containing an in-311 frame fusion to eGFP, so as to monitor viral replication. We collected protein lysates at 96 312 hours post-infection (hpi) in non-reducing conditions to preserve the protein S-313 nitrosylation modification of cysteines, since this modification is highly liable under 314 standard reducing conditions. We then biotinylated the protein S-nitrosylated cysteines 315 using a biotin switch assay (39), thus allowing for enrichment and subsequent peptide 316 identification by tandem mass spectrometry (MS/MS) analysis. MS/MS analysis of 317 fragmented peptides not only allows us to identify peptide amino acid sequences, but also 318 affords us the platform to characterize the specific cysteines that are increased in mass due 319 to the conjugated biotin. Thus, we can confirm protein S-nitrosylated of specific cysteines. 320
Using this methodology, we analyzed three independent, biological replicates each of mock 321 and infected MRC5 cells and identified more than 2000 peptides, representing 954 host proteins differentially S-nitrosylated in response to HCMV infection. Importantly, we 323 identified S-nitrosylation of 23 viral peptides originating from 13 different viral ORFs at 324 96 hpi (Table 1) , in which we also confirmed the presence of a modified cysteine in each 325 peptide (represented as a lower case "c" in the peptide sequence, Table 1) . 326
We were intrigued by S-nitrosylation of the UL82-encoded viral protein, pp71, 327 which is important for mediating host antiviral responses involving the interferon pathway. 328
In order to validate our MS/MS results, we repeated the infections and isolated equal 329 amounts of whole cell lysates for biotin-switch labeling. We then enriched the S-330 nitrosylated, biotin-labeled proteins by coupling them to streptavidin beads and then eluted 331 them for immunoblot blot analyses. A single protein band of the correct size and antigen 332 specificity for HCMV pp71 was detected from the biotin-switch assay enriched proteins, 333 thus confirming the modifications we identified in the MS/MS analyses ( Fig 1A, top panel) . 334
In addition, we performed the reverse pull-down, in which lysates from the biotin switch 335 reaction were immunoprecipitated with a pp71 specific antibody followed by blotting with 336 an anti-biotin specific antibody. We identified biotinylated pp71 protein (Fig 1A, bottom  337 panel), thereby verifying pp71 is specifically S-nitrosylated during infection of fibroblasts. 338
339
Mutation of protein S-nitrosylation identified cystine residues within pp71 does not inhibit 340 viral production. 341
To determine the biological function of the S-nitrosylated residue(s), we conducted 342 mutational analysis of pp71. We introduced mutations within pp71 in the context of the 343 viral BAC genome by changing each of the three identified S-nitrosylated cysteines to a 344 structurally similar serine (C34S, C94S, and C218S). The resulting BAC was used to 345 reconstitute the triple mutant pp71 virus (pp71-TM). To determine if the cysteine-to-serine 346 (Cys-to-Ser) mutations within pp71 inhibit the viability of virus production, we monitored 347 replication kinetics by viral growth analysis. To this end, we compared the single-step 348 growth of the pp71-TM virus to that of the wild-type/parental virus in MRC5 fibroblasts, 349 quantifying cell-free virus over a time course of 7 d (Fig 2A) . We did not observe a 350 significant viral growth defect when all three identified S-nitrosylated cysteines were 351 mutated to serine within pp71 (pp71-TM). In fact, pp71-TM viruses exhibited a slight, yet 352 consistent increase in both growth kinetics and cell-free viral yield when compared to wild-type virus (Fig 2A) . To determine whether the triple mutation described above altered viral 354 protein expression of pp71, we analyzed viral protein accumulation over a course of 355 infection by immunoblot. We found that, pp71-TM infected fibroblasts displayed similar 356 viral protein expression compared to its wild-type counterpart (Fig 2B) . To determine when 357 the Protein S-nitrosylation of cystines occurs on pp71, we analyzed the kinetics of this 358 PTM on pp71 in relation to de novo pp71 protein synthesis. Fibroblasts were infected with 359 wild-type HCMV and protein lysates were isolated at various timepoints. Lysates were 360 either used for western blot analysis of total pp71 protein expression or used in a biotin 361 switch assay, where S-nitrosylated proteins were captured with streptavidin beads and then 362 analyzed by western blot to assess pp71 protein S-nitrosylation ( Fig 3A) . We observed 363 similar kinetics between total pp71 expression and the appearance of the protein S-364 nitrosylation PTM on pp71 suggesting the modification on the protein occurs in a similar 365 time frame as protein synthesis. Thus, we focused on characterizing the biological effects 366 of pp71 S-nitrosylation. 367 pp71 is a multifunctional protein critical for efficient viral infection. Among its many 368 roles, pp71 interacts with pRb resulting in its degradation, mediated by the consensus pRb 369 binding motif LxCxD in pp71, where the central cysteine is located at amino acid 218 (14). 370
Our proteomic analysis revealed pp71 cysteine 218 (C218), the central cysteine of the pRb 371 binding motif, is S-nitrosylated (Table 1) . To elucidate the biological consequence(s) of 372 C218 S-nitrosylation, we introduced a single Cys-to-Ser mutation of C218, C218S, into 373 the wild-type BAC genome. We first determined whether C218 S-nitrosylation was critical 374 for tegument delivery of pp71 upon infection. We generated recombinant viruses and 375 assessed their ability to deliver tegument pp71 as well as the well characterized tegument 376 protein, pp65 as a control. At high moi infection of fibroblasts (MOI = 30), we detected 377 wild-type, as well as pp71-TM and pp71C218S at 6 hpi ( Fig 3B) . Although pp71 is a late 378 kinetic viral protein, its detection in newly infected cells early post-infection ( Fig 2B) and 379 prior to de novo synthesis is consistent with tegument-delivered pp71 (40). Together, these 380 results suggest the ability to inhibit protein S-nitrosylation of pp71 did not significantly 381 alter the growth kinetics or production of viral progeny when compared to the parental 382 virus. In addition, mutation of the identified protein S-nitrosylation modified cysteines did 383 not alter the expression, tegument loading, or delivery of pp71 to newly infected 384 fibroblasts. 385 386 Protein S-nitrosylated pp71 interacts with STING. 387
We next assessed the importance of protein S-nitrosylation for known biological 388 functions of pp71. Recent studies found pp71 could inhibit STING activation (21). 389
Inhibition of STING may be a universal feature of successful viruses, as both adenovirus 390
E1a and human papilloma virus E7 also inhibit STING anti-viral functions (41). E1a and 391 E7 mediate these interactions through their conserved LxCxE pRb binding domain. As our 392 analysis identified the central cysteine in the pp71 LxCxD domain was S-nitrosylated 393 during infection, we next asked whether this PTM affected pp71:STING interactions. 394
HEK293T cells lacking endogenous STING (42) were co-transfected with either empty 395 vector or a vector expressing HA-tagged STING (STING-HA) (34) in conjunction with 396 either FLAG-tagged wild-type pp71 (FLAG-WT-pp71) or FLAG-tagged pp71 bearing a 397 C218S mutation within the pRb binding domain (FLAG-pp71-C218S). First, we confirmed 398 the expression of each epitope-tagged protein by immunoblot analysis (Fig 4A) . 399
Transiently co-transfected cell lysates precipitated with anti-FLAG antibody followed by 400 immunoblot revealed both FLAG-WT-pp71 and FLAG-pp71-C218S each interact with 401 STING-HA (Fig 4A, top panel) . We also found the same interaction between FLAG-pp71-402 C218S or FLAG-WT-pp71 with STING-HA when we reversed the order of 403 immunoprecipitation, using an HA antibody followed by immunoblot with an anti-FLAG 404 antibody ( Fig 4A, bottom panel) . We observed STING-HA immunoprecipitated FLAG-405 pp71-C218S with greater efficiency than FLAG-WT-pp71, suggesting an increased 406 binding affinity of protein S-nitrosylation-defective pp71 for STING-HA ( Fig 4A, bottom  407 panel). Collectively, these results suggest STING interacts with pp71 and the interaction 408 may occur with greater affinity when pp71 C218 within its pRb-binding domain cannot 409 undergo protein S-nitrosylation. 410 To test our hypothesis that pp71 interacts with STING in the context of infection, 411
we performed immunofluorescent assays (IFAs) to monitor co-localization of pp71 and 412 endogenously expressed STING. Human fibroblasts were either mock-infected or infected 413 with a BAC-derived parental, TB40/e clone 4 (38) lacking a fluorescent gene. At 6 dpi, 414 cells were fixed and stained with antibodies that recognize pp71 and cellular STING. 415 STING was observed in both mock-infected and infected cells, whereas pp71 was 416 expressed only in infected cells ( Fig 4B) . Intracellular STING localization differed in 417 infected cells compared to mock-infected cells. In infected fibroblast, STING localized to 418 a perinuclear region where pp71 was also enriched, suggesting that the two proteins may 419 co-localize during infection (Fig 4B) , within subcellular regions consistent with the 420 localization of the viral assembly compartment (43). 421
Enhanced STING staining within infected cells leads one to question whether viral 422
infection results in the re-localization of endogenous STING or increased STING 423 expression in infected host cells. To test this, we infected NuFF-1 cells with either WT 424 HCMV or recombinant virus expressing pp71-C218S (MOI = 1.0). We collected total cell 425 lysates at time points relevant for tegument-delivered pp71 (Fig 3B) , as well as at time 426 points consistent with de novo protein synthesis of pp71 ( Fig 3A) . Neither tegument-427 delivered nor de novo protein synthesis of WT or mutant pp71 increased the relative 428 expression of endogenous STING compared to that of -tubulin (Figs 5A & B) . These 429 results reveal pp71 does not regulate endogenous STING expression levels, suggesting the 430 increased STING staining in the IFA was most likely due to altered subcellular localization 431 of STING. 432 433 pp71 protein S-nitrosylation limits its ability to undermine the STING antiviral pathway. 434
Since we observed small but reproducible increases in both growth kinetics and 435 absolute titer following lytic infection with the S-nitrosylation-deficient recombinant virus, 436 pp71-C218S, when compared to WT virus, we next investigated the biological impact of 437 pp71 S-nitrosylation on the STING pathway in the context of viral infection. To this end, 438
we generated a repair of the TB40/e-mCherry-pp71-C218S mutant, in which we restored 439 the serine mutation to cysteine, thus reverting the sequence to wild-type (C218Srev). The 440 use of this revertant ensures any phenotype we observed with the pp71p-C218S 441 recombinant virus was not caused by off-site mutations due to the recombineering. To 442 determine the effect of STING activation on viral replication, we treated MRC5 cells with 443 2'3'cGAMP and then infected the cells with WT, pp71-C218S, or pp71-C218Srev. 444 2'3'cGAMP is a natural ligand for STING activation (44), and a dose response curve 445 showed treatment of MRC5 fibroblasts with 10µM 2'3'cGAMP was sufficient to activate 446 STING signaling ( Supplementary Fig 1A) and had no adverse effect on cell viability, as 447 determined by MTT assay (Supplementary Fig 1B) . We then monitored cell-associated 448 HCMV genomes in MRC5s over a time course of viral infection. As expected, activation 449 of the potent antiviral STING pathway yielded low copies of cell-associated viral genomes 450 during WT or pp71-C218Srev infection (Fig 6A) . However, infection with the S-451 nitrosylation-deficient pp71 mutant virus, pp71-C218S, resulted in a significant increase 452 in cell-associated viral genomes (Fig 6A) , suggesting S-nitrosylation prevents pp71-453 mediated inactivation of STING. 454
We extended this analysis to monitor the impact of pp71 protein S-nitrosylation on 455 accumulation of infectious, cell-free virus in the presence of activated STING by single-456 step growth analysis. MRC5 cells were infected with WT, pp71-C218S, or pp71-C218Srev 457 (MOI = 1) in the presence of 2'3'cGAMP. Cell-free viral supernatants were collected over 458 time for quantification of viral production by TCID50. Analysis of the initial infectious 459 inoculum confirmed an equal amount of each virus was used in the experiment (Fig 6B,  460 Ino). We observed markedly diminished viral yield in both the WT-and pp71-C218Srev-461 infected fibroblasts in the presence of 10µM 2'3'cGAMP up to day 4 of the experiment 462 ( Fig 6B) . However, by 6 dpi both the WT-and pp71-C218Srev-infected cells began to 463 produce infectious progeny from the 2'3'cGAMP treated cells ( Fig 6B) . Importantly, 464 infection with pp71-C218S, the protein S-nitrosylation-deficient mutant virus, efficiently 465 accumulated infectious progeny even in the presence of 2'3'cGAMP across the time course 466 of infection. Together, these results suggest protein S-nitrosylation-deficient pp71 at 467 position C218 undermines potent STING activation compared to wild-type pp71. 468 469
Activated STING inhibits viral transcription of WT virus but not of pp71-C218S 470
To determine the stage of viral replication affected by pp71 S-nitrosylation 471 following STING activation, we monitored the accumulation of a subset of HCMV 472 transcripts within MRC5 cells. To this end, these fibroblasts were infected with WT, pp71-473 C218S, or pp71-C218Srev in the presence or absence of STING activation. Viral 474 transcripts UL122, UL54, and UL32 were selected as representative genes of each infection 475 stage (e.g.: immediate early (IE), early (E), and late (L), respectively (45)). In the absence of STING activation, the expression and accumulation of HCMV transcripts were similar 477 to each other when compared across each virus infection (Fig 7A, upper panel) . As 478 expected, activation of the STING pathway with 2'3'cGAMP treatment prior to infection 479 significantly inhibited the expression and accumulation of HCMV transcripts in the 480 fibroblasts that were infected with either WT or pp71-C218Srev viruses. However, 481 2'3'cGAMP treatment did not impair the transcription of these viral genes in the pp71-482 C218S infected fibroblasts (Fig 7A, lower panel) . Indeed, the viral transcript levels in the 483 pp71-C218S infected cells in the presence of 2'3'cGAMP ( Fig 7A, lower panel) to accumulation of cytokines and interferon genes, both of which limit viral replication. To 494 determine whether protein S-nitrosylation of pp71 impacts these transcriptional pathways 495 after STING activation, 2'3'cGAMP treated MRC5 cells were infected with WT, pp71-496 C218S, or pp71-C218Srev and the expression of NF B-and IRF3-responsive genes was 497 quantified by RT-qPCR. As expected, expression of IFN 1 was upregulated at both 8 and 498 24 hpi in WT and pp71-C218Srev infected cells following STING activation, however, 499 induction of IFN 1 was suppressed in pp71-C218S infected cells (Fig. 7B) . Expression of 500 the NF B-responsive IL-1 transcript was equally suppressed with each of the viruses 501 used, suggesting the inhibition was independent of C218 S-nitrosylation. Previous studies 502 showed HCMV-encoded proteins, pUL26 and pp65 inhibit the NF B pathway (46, 47) . As 503 pUL26 and pp65 were expressed in the three viruses used in this stud, we desired to 504 evaluate pp71 protein S-nitrosylation in the absence of other viral proteins. However, our 505 observations strongly suggest the induction of IFN 1 transcription following the activation 506 of STING is inhibited by pp71 deficient for protein S-nitrosylation at C218. 507 508 pp71 functions to inhibit STING-mediated transcription independent of other viral factors. 509
We have shown blocking protein S-nitrosylation of pp71 is necessary for efficient 510 inhibition of STING-induced transcription. Thus, we next determined if blocking this PTM 511 is sufficient by assessing pp71 in the absence of viral infection. To this end, MRC5s stably 512 transduced with lentiviral constructs that allow for the stable expression of either WT-pp71 513 (M5-pp71WT) or S-nitrosylation-deficient pp71, pp71-C218S (M5-pp71c218S) were 514 generated ( Fig 8A) . We next determined whether exogenously expressed pp71 was S-515 nitrosylated in the absence of HCMV infection. We performed the biotin-switch assay on 516 lysates from M5-pp71WT transduced cells and found pp71 was indeed S-nitrosylated ( Fig  517   8B ), suggesting this PTM occurs independent of any additional viral proteins. We did not 518 perform this analysis on the M5-pp71c218S cells as this mutant pp71 construct still contains 519 the remaining two cysteines (C34 and C94) that we showed are nitrosylated (Table 1) . 520
Thus, this mutant would still display protein S-nitrosylation, as this methodology does not 521 distinguish the location of the PTM. 522
To determine whether stable expression of either WT or mutant pp71 impacts 523 interferon induction in fibroblasts in the absence of infection, we treated the transduced 524 cells with 2'3'cGAMP and monitored transcription of STING-responsive transcripts by 525 RT-qPCR. We found the M5-pp71c218S cells displayed a significant reduction of IFN 1 526 when compared to the M5-pp71WT cells (Fig. 8C ). As we performed these experiments in 527 the absence of any other HCMV proteins that may impact NFkB, we were able to 528 characterize the impact of pp71 S-nitrosylation on the NFkB-mediated pathway by 529 quantifying IL-1 express. In support of our hypothesis that pp71 S-nitrosylation affects 530 the inhibition of the STING pathway, our data revealed IL-1 expression was significantly 531 inhibited by overexpression of pp71-C218S compared to WT-pp71 ( Fig. 8C ). Together, 532 these results reveal pp71 inhibited STING-mediated signal transduction, as previously 533 reported, thereby attenuating the STING antiviral response. Importantly, pp71 S-534 nitrosylation impeded this STING inhibition, and a single amino acid substitution within 535 the pRb-binding domain of pp71 was sufficient to relieve this repression.
DISCUSSION 537
We undertook an unbiased approach to identify and characterize the HCMV viral 538 proteome that undergoes protein S-nitrosylation during lytic infection. As this modification 539 is reversible, we hypothesized this PTM would play distinct roles at different points of the 540 lytic life cycle. To this end, we characterized the S-nitrosylated proteome at a time point 541 during infection in which viral DNA has initiated and assembly of infectious progeny has 542 begun (96 hpi). We chose this time point for two reasons: 1) most viral proteins are 543 expressed at high levels at this time, and 2) protein S-nitrosylation is a known host response 544 to stress (48). It should be noted this methodology may overlook viral proteins with short 545 half-lives, transient protein S-nitrosylation modifications, and peptides from viral ORFs 546 not present at this time during infection. In three biological replicates, we consistently 547 identified 13 viral proteins from each kinetic class of HCMV proteins that are S-548 nitrosylated ( Table 1) with more than half of these peptides originating from tegument 549 proteins. 550
Of particular interest was the identification of three distinct S-nitrosylation sites 551 within pp71. The tegument viral protein pp71 has multiple, critical biological functions 552 which promote efficient viral replication by undermining host antiviral responses. 553
Specifically, tegument delivered pp71 functions to degrade hDAXX as well as pRb, thus 554 relieving repression of viral transcription and promoting entry into the cell cycle of the 555 infected host cell, respectively (14) (15) (16) (17) 49) . Thus, evaluating the impact of pp71 protein S-556 nitrosylation was a primary focus. With advancements in bacterial artificial chromosome 557 (BAC) recombineering technology, we are able to mutate and evaluate the requirement of 558 specific protein motifs in viral proteins within the context of an active infection. We 559 mutated each of the S-nitrosylated cysteines we identified in pp71 to the closely related 560 amino acid serine, which is incapable of protein S-nitrosylation. Unexpectedly, mutation 561 of the modified cysteines within pp71 resulted in a viable virus that replicated with a 562 modest, yet consistently better efficiency than wild-type virus (Fig 2A) . We had 563 hypothesized any deleterious mutation would result in a growth defect in the virus, 564 especially as one of the mutated cysteines was located within the LxCxE/D domain 565 previously identified in pp71 to mediate the pRb binding functions (14). However, 566 mutations of all three identified protein S-nitrosylated cysteines to serines within pp71 567 resulted in nearly equal amounts of viral protein accumulation when compared to wild-568 type ( Fig 3A) and no apparent defect in tegument loading of pp71 into cell-free virions 569 ( Fig 3B) suggesting that these mutations resulted in no apparent biological defect within 570 highly permissive fibroblasts. 571
More recently, pp71 expression has been implicated in undermining the STING-572 induced response in HCMV-infected cells (21). STING is an adaptor protein involved in 573 mediating the response between activated cytoplasmic DNA sensors and the type I 574 interferon response pathway. STING activation, induced by encountering the secondary 575 signaling mediator 2'3'cGAMP, promotes a potent antiviral state resulting in NFkB-576 mediated transcriptional activation of cytokines and IRF3-mediated transcriptional 577 activation of interferon genes. Thus, pp71's ability to undermine STING activation is 578 critical for efficient viral replication. Importantly, proteins encoded by other viruses 579 undermine STING responses. Human papilloma virus E7 and human adenovirus E1a both 580 interact with STING, and these interactions require the LxCxE/D pRb-binding motif found 581 in each of these viral proteins (41). Importantly the best-characterized protein S-582 nitrosylation motif is the I/LxCx2E/D motif, initially characterized in regulating the 583 function of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) within the interferon-584 activated inhibitor of translation (GAIT) complex (50). Protein S-nitrosylation regulates 585 the function of the GAIT complex, thus restoring translation of specific transcripts during 586 times of interferon activation (51). This motif differs from the canonical pRb binding motif 587 by only the spacing of a single amino acid. Thus, we hypothesized the protein S-588 nitrosylation of the central cysteine within pp71's pRB-binding domain is critical for the 589 interaction of this viral protein with STING. 590
We further investigated the biological impact of pp71 S-nitrosylation on the STING 591 pathway. We observed, as previously reported (21), pp71 immunoprecipitated with 592 STING, but we noted increased precipitation of the two proteins when we mutated the 593 central cysteine in pp71's pRb-binding domain to serine, thus blocking S-nitrosylation (Fig  594   4A ). This suggests that S-nitrosylation of pp71 may be inhibitory to its biological functions. 595
The interaction of pp71 with STING did not result in degradation of this host protein (Fig  596   5A&B ), suggesting the mechanism of inhibiting the interferon pathway differs from how 597 pp71 inhibits the transcriptional inhibitor, hDAXX. 598
To evaluate the impact of pp71 S-nitrosylation on the STING pathway, we assessed 599 viral replication in the presence of the natural ligand for STING activation, 2'3'cGAMP. 600
In support of our model, we observed inhibition of wild-type HCMV during activation of 601 the STING pathway, but this attenuation was less pronounced when pp71 S-nitrosylation 602 was blocked by the Cys-to-Ser mutation ( Fig 6A&B) . The net effect was a decrease in the 603 production of antiviral cytokine and interferon transcripts (Fig 8) . This led us to the novel 604 interpretation that host-directed S-nitrosylation of virulence factors may function as an 605 additional antiviral measure, thus limiting viral replication. As viral proteins essential for 606 replication of other unrelated viruses (e.g. human papillomavirus and human adenovirus) 607 have conserved motifs to pp71's protein S-nitrosylation site through which they interact 608 with STING, we favor a model where host cell mediated PTMs function to limit additional 609 pathogens beyond HCMV, thus suggesting a more universal function for protein S-610 nitrosylation. 611
Why would HCMV pp71 evolve to maintain a motif that limits its capacity to 612 replicate in the face of potent antiviral responses? Data suggests S-nitrosylation of 613 cysteines within proteins is not random and that this modification is mediated by specific 614 nitrosyltransferases selective for specific, conserved cysteines (52). One could speculate 615 that there would be a benefit to pp71 altering this central cysteine, however, the pp71's 616 pRb-binding function is important during infection of certain cell types (53), thus 617 maintaining this cysteine has a fitness benefit for the virus. It will be interesting to discern 618 the extent of protein S-nitrosylation of different viral proteins to determine if this 619 mechanism of host-mediated antiviral responses is more universal and potentially 620 exploitable as an antiviral therapy. In sum, we have identified and characterized a novel 621 pp71 PTM that functions as an additional host-mediated antiviral measure in response to 622 infection. The balance between a successful infection and an abortive infection pivots on 623 the ability of a virus to undermine host countermeasures to infection. We favor a model in 624 which host cells are able to sense the initial shift towards successful viral replication and 625 in response, the host cell induces pathways resulting in the accumulation of post 626 translational modifications that incapacitate or limit potent viral virulence factors, such as 627 pp71. In doing so, host cells can slow viral spread. Identifying the direct factors that dictate 628 these responses will be of high value. 629
